Peer reviewed
Lifespan benefits of rapamycin in three genetically diverse mouse populations (ITP repeat study)
Multi-site replication confirming lifespan extension by rapamycin across genetically diverse mouse populations, supporting the robustness of the original ITP finding.
Nature Communications / NIA Interventions Testing ProgramPublished 2020-06-10Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- Nature Communications / NIA Interventions Testing Program
- Source type
- Peer reviewed
- Registry ID
nih-itr-rapamycin-repeat-2020
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.